Terry MB, Gaudet MM, Gammon MD: The epidemiology of gastric cancer. Semin Radiat Oncol. 2002, 12 (2): 111-127. 10.1053/srao.30814.
Article
PubMed
Google Scholar
Li C, Oh SJ, Kim S, Hyung WJ, Yan M, Zhu ZG, Noh SH: Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size. J Gastrointest Surg. 2009, 13 (5): 881-885. 10.1007/s11605-009-0800-3.
Article
PubMed
Google Scholar
Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 1991, 51 (18 Suppl): 5054s-5059s.
CAS
PubMed
Google Scholar
Wu CY, Wu MS, Chiang EP, Chen YJ, Chen CJ, Chi NH, Shih YT, Chen GH, Lin JT: Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin Cancer Res. 2007, 13 (7): 2054-2060. 10.1158/1078-0432.CCR-06-2299.
Article
CAS
PubMed
Google Scholar
Kubben FJGM, Sier CFM, van Duijn W, Griffioen G, Hanemaaijer R, Velde van de CJH, van Krieken JHJM, Lamers CBHW, Verspaget HW: Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer. 2006, 94 (7): 1035-1040. 10.1038/sj.bjc.6603041.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deng H, Guo RF, Li WM, Zhao M, Lu YY: Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. Biochem Biophys Res Commun. 2005, 326 (2): 274-281. 10.1016/j.bbrc.2004.11.027.
Article
CAS
PubMed
Google Scholar
Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S: Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci. 2003, 94 (1): 43-49. 10.1111/j.1349-7006.2003.tb01350.x.
Article
CAS
PubMed
Google Scholar
Vlodavsky I, Ilan N, Naggi A, Casu B: Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des. 2007, 13 (20): 2057-2073. 10.2174/138161207781039742.
Article
CAS
PubMed
Google Scholar
Nakajima M, Irimura T, Di Ferrante N, Nicolson GL: Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem. 1984, 259 (4): 2283-2290.
CAS
PubMed
Google Scholar
Nasser NJ: Heparanase involvement in physiology and disease. Cell Mol Life Sci. 2008, 65 (11): 1706-1715. 10.1007/s00018-008-7584-6.
Article
CAS
PubMed
Google Scholar
Ikeguchi M, Fukuda K, Yamaguchi K, Kondo A, Tsujitani S, Kaibara N: Quantitative analysis of heparanase gene expression in esophageal squamous cell carcinoma. Ann Surg Oncol. 2003, 10 (3): 297-304. 10.1245/ASO.2003.05.022.
Article
PubMed
Google Scholar
Kim AW, Xu X, Hollinger EF, Gattuso P, Godellas CV, Prinz RA: Human heparanase-1 gene expression in pancreatic adenocarcinoma. J Gastrointestinal Surg. 2003, 6 (2): 167-172. 10.1016/S1091-255X(01)00087-7.
Article
Google Scholar
Rivera RS, Nagatsuka H, Siar CH, Gunduz M, Tsujigiwa H, Han PP, Katase N, Tamamura R, Ng KH, Naomoto Y, Nakajima M, Nagai N: Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma. Oncol Rep. 2008, 19 (3): 657-661.
PubMed
Google Scholar
Kazu G, Masa O, Sohe K, Mina T, Jian D, Yoji K, Moto N: Heparanase protein and gene expression in bladder cancer. J Urol. 2001, 166 (4): 1286-1290. 10.1016/S0022-5347(05)65754-0.
Article
Google Scholar
Stadlmann S, Moser PL, Pollheimer J, Steiner P, Krugmann J, Dirnhofer S, Mikuz G, Margreiter R, Amberger A: Heparanase-1 gene expression in normal, hyperplastic and neoplastic prostatic tissue. Eur J Cancer. 2003, 39 (15): 2229-2233. 10.1016/S0959-8049(03)00457-X.
Article
CAS
PubMed
Google Scholar
Vlodavsky I, Ilan N, Nadir Y, Brenner B, Katz BZ, Naggi A, Torri G, Casu B, Sasisekharan R: Heparanase, heparin and the coagulation system in cancer progression. Thromb Res. 2007, 120 (Supplement 2): S112-S120. 10.1016/S0049-3848(07)70139-1.
Article
PubMed
Google Scholar
Wang Z, Xu H, Jiang L, Zhou X, Lu C, Zhang X: Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma. Mod Pathol. 2004, 18 (2): 205-211. 10.1038/modpathol.3800282.
Article
Google Scholar
Takaoka M, Naomoto Y, Ohkawa T, Uetsuka H, Shirakawa Y, Uno F, Fujiwara T, Gunduz M, Nagatsuka H, Nakajima M, Tanaka N, Haisa M: Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab Invest. 2003, 83 (5): 613-622.
Article
CAS
PubMed
Google Scholar
Bar-Ner M, Eldor A, Wasserman L, Matzner Y, Cohen IR, Fuks Z, Vlodavsky I: Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood. 1987, 70 (2): 551-557.
CAS
PubMed
Google Scholar
Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA, Nicolson GL: Suramin. A potent inhibitor of melanoma heparanase and invasion. J Biol Chem. 1991, 266 (15): 9661-9666.
CAS
PubMed
Google Scholar
Simizu S, Ishida K, Wierzba MK, Osada H: Secretion of heparanase protein is regulated by glycosylation in human tumor cell lines. J Biol Chem. 2004, 279 (4): 2697-2703. 10.1074/jbc.M300541200.
Article
CAS
PubMed
Google Scholar
Levidiotis V, Freeman C, Punler M, Martinello P, Creese B, Ferro V, Vlag van der J, Berden JHM, Parish CR, Power DA: A Synthetic Heparanase Inhibitor Reduces Proteinuria in Passive Heymann Nephritis. J Am Soc Nephrol. 2004, 15 (11): 2882-2892. 10.1097/01.ASN.0000142426.55612.6D.
Article
CAS
PubMed
Google Scholar
Hua-Quan M, Hu L, Navarro E, Kussie P, Zhenping Z: Development of heparanase inhibitors for anti-cancer therapy. Curr Med Chem. 2006, 13 (18): 2101-2111. 10.2174/092986706777935230.
Article
Google Scholar
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001, 411 (6836): 494-498. 10.1038/35078107.
Article
CAS
PubMed
Google Scholar
Izquierdo M: Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther. 2004, 12 (3): 217-227. 10.1038/sj.cgt.7700791.
Article
Google Scholar
Mathews DH, Sabina J, Zuker M, Turner DH: Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol. 1999, 288 (5): 911-940. 10.1006/jmbi.1999.2700.
Article
CAS
PubMed
Google Scholar
Nicosia RF, Ottinetti A: Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest. 1990, 63 (1): 115-122.
CAS
PubMed
Google Scholar
Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, Peretz T, Vlodavsky I, Abramovitch R: Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer. 2006, 118 (7): 1609-1617. 10.1002/ijc.21552.
Article
CAS
PubMed
Google Scholar
Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I, Vlodavsky I: Heparanase as mediator of angiogenesis: mode of action. FASEB J. 2001, 15 (9): 1661-1663.
CAS
PubMed
Google Scholar
Vlodavsky I, Friedmann Y: Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001, 108 (3): 341-347.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boyd D: Invasion and metastasis. Cancer Metastasis Rev. 1996, 15 (1): 77-89. 10.1007/BF00049488.
Article
CAS
PubMed
Google Scholar
Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I: Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999, 5 (7): 793-802. 10.1038/10518.
Article
CAS
PubMed
Google Scholar
Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med. 1999, 5 (7): 803-809. 10.1038/10525.
Article
CAS
PubMed
Google Scholar
McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, Hircock M, Patel S, Barry E, Stubberfield C, Terrett J, Page M: Cloning and expression profiling of hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun. 2000, 276 (3): 1170-1177. 10.1006/bbrc.2000.3586.
Article
CAS
PubMed
Google Scholar
Bar-Sela G, Kaplan-Cohen V, Ilan N, Vlodavsky I, Ben-Izhak O: Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival. Histopathology. 2006, 49 (2): 188-193. 10.1111/j.1365-2559.2006.02469.x.
Article
CAS
PubMed
Google Scholar
Ikeguchi M, Hirooka Y, Kaibara N: Heparanase gene expression and its correlation with spontaneous apoptosis in hepatocytes of cirrhotic liver and carcinoma. Eur J Cancer. 2003, 39 (1): 86-90. 10.1016/S0959-8049(02)00558-0.
Article
CAS
PubMed
Google Scholar
Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A, Buchler MW: Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 2001, 61 (12): 4655-4659.
CAS
PubMed
Google Scholar
Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I: Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst. 2004, 96 (16): 1219-1230.
Article
CAS
PubMed
Google Scholar
Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I: Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer. 1999, 83 (3): 424-431. 10.1002/(SICI)1097-0215(19991029)83:3<424::AID-IJC20>3.0.CO;2-L.
Article
CAS
PubMed
Google Scholar
Karoli T, Liu L, Fairweather JK, Hammond E, Li CP, Cochran S, Bergefall K, Trybala E, Addison RS, Ferro V: Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). J Med Chem. 2005, 48 (26): 8229-8236. 10.1021/jm050618p.
Article
CAS
PubMed
Google Scholar
Khvorova A, Reynolds A, Jayasena SD: Functional siRNAs and miRNAs exhibit strand bias. Cell. 2003, 115 (2): 209-216. 10.1016/S0092-8674(03)00801-8.
Article
CAS
PubMed
Google Scholar
Schwarz DS, Hutvágner Gr, Du T, Xu Z, Aronin N, Zamore PD: Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003, 115 (2): 199-208. 10.1016/S0092-8674(03)00759-1.
Article
CAS
PubMed
Google Scholar
Kretschmer-Kazemi Far R, Sczakiel G: The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucl Acids Res. 2003, 31 (15): 4417-4424. 10.1093/nar/gkg649.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luo KQ, Chang DC: The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region. Biochem Biophys Res Commun. 2004, 318 (1): 303-310. 10.1016/j.bbrc.2004.04.027.
Article
CAS
PubMed
Google Scholar
Heale BSE, Soifer HS, Bowers C, Rossi JJ: siRNA target site secondary structure predictions using local stable substructures. Nucl Acids Res. 2005, 33 (3): e30-10.1093/nar/gni026.
Article
PubMed
PubMed Central
Google Scholar
Patzel V: In silico selection of active siRNA. Drug Discov Today. 2007, 12 (3-4): 139-148. 10.1016/j.drudis.2006.11.015.
Article
CAS
PubMed
Google Scholar
Schubert S, Grünweller A, Erdmann VA, Kurreck J: Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J Mol Biol. 2005, 348 (4): 883-893. 10.1016/j.jmb.2005.03.011.
Article
CAS
PubMed
Google Scholar
Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H: Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucl Acids Res. 2002, 30 (8): 1757-1766. 10.1093/nar/30.8.1757.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, Elkin M, Peretz T, Friedmann Y: Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol. 2002, 12 (2): 121-129. 10.1006/scbi.2001.0420.
Article
CAS
PubMed
Google Scholar
Liu Tg, Yin JQ, Shang By, Min Z, He Hw, Jiang Jm, Chen F, Zhen Ys, Shao Rg: Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer. Cancer Gene Ther. 2004, 11 (11): 748-756. 10.1038/sj.cgt.7700753.
Article
CAS
PubMed
Google Scholar